FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
Activated Insights Announces 2025 Customer Experience Award™ Winners, Recognizing Excellence in Long-Term and Post-Acute Care
Activated Insights, the leading provider of training, recruitment, retention, experience management and recognition tools to ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
New Atlas3h
FDA approves new class of painkiller – the first in more than 20 years
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
Cure Today8h
Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia
Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...
Business Wire6h
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigin ...
News Medical on MSN3h
Psilocybin promotes lasting belief change by altering neural entropy
Psilocybin significantly reduces confidence in negative self-beliefs four weeks after administration, with effects linked to ...
New Study Published in JAMA Network Open Finds Procedural Prescription Denials Can Increase Acute Care Utilization and Spending in Medicaid
A new study published in JAMA Network Open has found that while procedural prescription denials curb immediate drug costs, some denials result in increased acute care utilization and costs, which ...
Patients 'frightened' to go to hospital over lengthy ED waits
Northern Ireland's hospitals have recently experienced significant issues with excessive waiting times.
Funding announcement for RVH will see acute care and complex continuing care units upgraded
Calling it a “game changer” for Renfrew Victoria Hospital (RVH), Renfrew-Nipissing-Pembroke MPP John Yakabuski said the ...
New non-opioid painkiller approved by US health agency
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...